Streetbeat News

Regulatory

RVSN

Rail Vision Ltd. (NASDAQ:RVSN) stock surged after announcing its Main Line system received EU railway standards certifications. This achievement is seen as a major milestone, positioning Rail Vision ahead in the railway technology market. The company also recently entered the US market with a $5 million contract for its AI-based Switch Yard Systems. Rail Vision's stock is trending with heavy trading volume, significantly exceeding its 100-day average.

Portfolio Pulse from Erica Kollmann

January 23, 2024 | 5:58 pm

EWJ

SPY

X

Nippon Steel sent a delegation to Washington to discuss its $14 billion acquisition of U.S. Steel with lawmakers and analysts. The deal faced opposition from lawmakers, including Sen. John Fetterman, due to concerns over national security. White House Adviser Brainard emphasized the importance of steel to national security.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 5:58 pm

RVSN

Rail Vision's stock (RVSN) is experiencing an increase in value due to the positive momentum following the announcement that its Main Line system has received formal certifications for key European Union railway standards.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 5:56 pm

BNBUSD

Binance (CRYPTO: BNB) is seeking to have a lawsuit by the SEC dismissed, following a $4.3 billion settlement with the DOJ and CFTC over finance violations. The SEC's lawsuit alleges Binance of fraud and rule violations, including trading of unregistered securities. The outcome of the case could significantly impact the regulatory landscape for cryptocurrencies.

Portfolio Pulse from Murtuza Merchant

January 23, 2024 | 5:38 pm

EIS

SPY

USO

US Middle East Envoy McGurk is in Cairo today for discussions on hostages in the region, aiming for another hostage deal and a humanitarian pause. The visit also includes assessing IDF operations. The White House's Kirby confirms active conversations are ongoing.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 5:30 pm

OTLK

Outlook Therapeutics' stock is up following the FDA's agreement under a Special Protocol Assessment (SPA) for the NORSE EIGHT clinical trial. Additionally, the company has announced a private placement worth up to $172 million to fund the advancement of ONS-5010.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 5:09 pm

ET

Kelcy Warren, Chairman of Energy Transfer, stated that he does not anticipate the US Army Corps of Engineers to shut down the Dakota Access Oil Pipeline. He also mentioned that the company is not affected by the Corps' draft of a more intensive environmental impact study for the pipeline.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 4:53 pm

GILD

Gilead Sciences Inc. has announced its intention to collaborate with the FDA regarding a product labeling request. The company has stated that there is no evidence to date that suggests a causal relationship between its treatments Yescarta or Tecartus and the development of T-cell origin malignancies.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 4:28 pm

GILD

Gilead Sciences has stated that there is no change to the FDA's stance on the benefits of Car T-cell therapies, including Yescarta and Tecartus, outweighing potential risks. The company expresses confidence in the benefit-risk profile of both treatments.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 4:27 pm

XPEV

XPeng Inc – ADR (NYSE:XPEV) stock rose by 2.25% to $9.55 amid news of China considering a 2 trillion yuan ($278 billion) stock market rescue package. The fund, sourced from offshore accounts of Chinese state-owned enterprises, aims to stabilize the market by purchasing shares through the Hong Kong exchange link. This move comes as foreign investors have been withdrawing from the Chinese equity market, causing declines in Chinese stocks on Hong Kong's Hang Seng Index.

Portfolio Pulse from Henry Khederian

January 23, 2024 | 4:19 pm